Home › Funds › RA CAPITAL MANAGEMENT, L.P. › LBRX

RA CAPITAL MANAGEMENT, L.P. position in LBRX

LB PHARMACEUTICALS INC · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 2,208,604 shares of LBRX (LB PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$71.7M, representing 0.62% of its reported portfolio and ranking #31 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)2.21M sh
Reported value held$71.68M
Portfolio Weight0.62%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s LBRX position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in LBRX in Q3 2025 at 1,776,958 shares (US$28.1M). The position peaked in Q2 2026 at 2,208,604 shares, worth US$71.7M. Across 4 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,208,604 shares valued at US$71.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.78M $28.06M New
Q4 2025 2.21M $49.16M Add
Q1 2026 2.21M $54.46M Hold
Q2 2026 2.21M $71.68M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 110 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), Trails Edge Capital Partners, LP (US$49.4M), Commodore Capital LP (US$48.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held LBRX?

RA CAPITAL MANAGEMENT, L.P. has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in LBRX?

As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 2.21M shares of LBRX (LB PHARMACEUTICALS INC), valued at $71.68M, representing 0.62% of its reported portfolio and ranking #31.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling LBRX?

In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in LBRX. The position peaked in Q2 2026 at 2.21M shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, Trails Edge Capital Partners, LP, Commodore Capital LP, among 110 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.